David S Shulman

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 18

Top Venues

Pediatric blood & cancer

Cancer medicine

Journal of clinical medicine

British journal of cancer

Dana Farber Cancer Institute

Union College (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Dana Farber Cancer Institute Jul 01 2016

United States

Pediatric Oncology Fellow :: Pediatric Oncology

Boston Children's Hospital Jul 01 2013 - Jun 30 2016

United States

Resident Physician :: Medicine

Education History

Union College Sep 01 2004 - Jun 01 2008

United States

BSC

Publications

Ajami Gikandi, Susan N Chi, Kee Kiat Yeo, Allison F O'Neill, David S Shulman, Steven G DuBois, Natalie B Collins
Off-label prescribing of immune checkpoint inhibitor therapy at a single pediatric cancer center. Cancer medicine 13 (8) (2024)
Ajami Gikandi, Susan N Chi, Kee Kiat Yeo, Allison F O'Neill, David S Shulman, Steven G DuBois, Natalie B Collins
Off-label prescribing of immune checkpoint inhibitor therapy at a single pediatric cancer center. Cancer medicine 13 (8) (2024)
Ajami Gikandi, Susan N Chi, Kee Kiat Yeo, Allison F O'Neill, David S Shulman, Steven G DuBois, Natalie B Collins
Off-label prescribing of immune checkpoint inhibitor therapy at a single pediatric cancer center. Cancer medicine 13 (8) (2024)
David S Shulman, Priscilla Merriam, Edwin Choy, Lillian M Guenther, Kerri L Cavanaugh, Pei-Chi Kao, Andrew Posner, Ketki Bhushan, Grace Fairchild, Emma Barker, Kelly Klega, Kimberly Stegmaier, Brian D Crompton, Wendy B London, Steven G DuBois
Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcoma. Cancer medicine (2023)
Hannah E Olsen, Kevin X Liu, A Lindsay Frazier, Allison F O'Neill, Katherine A Janeway, Steven G DuBois, David S Shulman
Evaluation of prevalence and outcomes of serial tyrosine kinase inhibitor use in pediatric patients with advanced solid tumors. Pediatric blood & cancer (2023)
Kevin M Campbell, Andrew Posner, Nan Chen, Kerri Cavanaugh, Ketki Bhushan, Katherine A Janeway, David S Shulman, Suzanne George, Kelly Klega, Brian Crompton, Wendy B London, Steven G DuBois
Phase 1 study of cabozantinib in combination with topotecan-cyclophosphamide for patients with relapsed Ewing sarcoma or osteosarcoma. Pediatric blood & cancer (2023)
Dylan V Neel, Clement Ma, Natalie B Collins, Jason L Hornick, George D Demetri, David S Shulman
Derivation and validation of a risk classification tree for patients with synovial sarcoma. Cancer medicine (2022)
David S Shulman, Sonja Chen, David Hall, Anwesha Nag, Aaron R Thorner, Stephen L Lessnick, Kimberly Stegmaier, Katherine A Janeway, Steven G DuBois, Mark D Krailo, Donald A Barkauskas, Alanna J Church, Brian D Crompton
Adverse prognostic impact of the loss of STAG2 protein expression in patients with newly diagnosed localised Ewing sarcoma: A report from the Children's Oncology Group. British journal of cancer 127 (12) (2022)
David S Shulman, Lulla V Kiwinda, Stacey Edwards, Catherine M Clinton, Sarah Hunt, Lianne Greenspan, Kristen D Lawler, Gregory Reaman, Hasan Al-Sayegh, Kira Bona, Allison F O'Neill, Suzanne Shusterman, Katherine A Janeway, Andrew E Place, Susan N Chi, Clement Ma, Steven G DuBois
Retrospective evaluation of single patient investigational new drug (IND) requests in pediatric oncology. Cancer medicine (2021)
Stefan K Zöllner, James F Amatruda, Sebastian Bauer, Stéphane Collaud, Enrique de Álava, Steven G DuBois, Jendrik Hardes, Wolfgang Hartmann, Heinrich Kovar, Markus Metzler, David S Shulman, Arne Streitbürger, Beate Timmermann, Jeffrey A Toretsky, Yasmin Uhlenbruch, Volker Vieth, Thomas G P Grünewald, Uta Dirksen
Ewing Sarcoma-Diagnosis, Treatment, Clinical Challenges and Future Perspectives. Journal of clinical medicine 10 (8) (2021)
Kevin M Campbell, David S Shulman, Holcombe E Grier, Steven G DuBois
Role of bone marrow biopsy for staging new patients with Ewing sarcoma: A systematic review. Pediatric blood & cancer 68 (2) (2020)
Jaclynne H Nader, Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Landscape of phase 1 clinical trials for minors with cancer in the United States. Pediatric blood & cancer 67 (11) (2020)
Lenka A Ilcisin, Clement Ma, Katherine A Janeway, Steven G DuBois, David S Shulman
Derivation and validation of risk groups in patients with osteosarcoma utilizing regression tree analysis. Pediatric blood & cancer 68 (3) (2020)
Kevin X Liu, Natalie B Collins, Katie A Greenzang, Elissa Furutani, Kevin Campbell, Andrew Groves, Elizabeth A Mullen, Suzanne Shusterman, Jennifer Spidle, Karen J Marcus, Brent R Weil, Christopher B Weldon, A Lindsay Frazier, Katherine A Janeway, Allison F O'Neill, Jennifer W Mack, Steven G DuBois, David S Shulman
The use of interval-compressed chemotherapy with the addition of vincristine, irinotecan, and temozolomide for pediatric patients with newly diagnosed desmoplastic small round cell tumor. Pediatric blood & cancer 67 (10) (2020)
Jennifer Caruso, David S Shulman, Steven G DuBois
Second malignancies in patients treated for Ewing sarcoma: A systematic review. Pediatric blood & cancer 66 (11) (2019)
Samuel D Abbou, David S Shulman, Steven G DuBois, Brian D Crompton
Assessment of circulating tumor DNA in pediatric solid tumors: The promise of liquid biopsies. Pediatric blood & cancer 66 (5) (2019)
David S Shulman, Steven G DuBois
Winning the RACE: Expanding pediatric cancer drug approvals. Pediatric blood & cancer 66 (8) (2019)
David S Shulman, Preeti Mehrotra, Traci M Blonquist, Andrew Capraro, Leslie E Lehmann, Lewis B Silverman, Neeraj K Surana, Andrew E Place
A single institutional review of pediatric Bacillus spp. bloodstream infections demonstrates increased incidence among children with cancer. Pediatric blood & cancer 66 (4) (2018)

David S Shulman.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

David S Shulman